Hydroxyzine hydrochloride and Anoro ellipta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hydroxyzine hydrochloride (hydroxyzine hydrochloride) and Anoro ellipta (umeclidinium bromide; vilanterol trifenatate). Common drug interactions include pain among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Hydroxyzine hydrochloride and Anoro ellipta. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Hydroxyzine hydrochloride?

Hydroxyzine hydrochloride has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 10,486 Hydroxyzine hydrochloride users. Check the latest studies of Hydroxyzine hydrochloride.

What is Anoro ellipta?

Anoro ellipta has active ingredients of umeclidinium bromide; vilanterol trifenatate. eHealthMe is studying from 16,515 Anoro ellipta users. Check the latest studies of Anoro ellipta.



On Jul, 15, 2026

24 people who take Hydroxyzine hydrochloride and Anoro ellipta together, and have interactions are studied.

Hydroxyzine hydrochloride and Anoro ellipta drug interactions.

What are the common drug interactions of Hydroxyzine Hydrochloride and Anoro Ellipta, by gender? *:

female:

  1. Pain
  2. Headache (pain in head)
  3. Dyspnoea (difficult or laboured respiration)
  4. Fatigue (feeling of tiredness)
  5. Weight decreased
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Vomiting
  8. Gastrointestinal viral infection (virus infection of gastrointestinal tract)
  9. Infusion site swelling
  10. Migraine (headache)

male:

  1. Renal failure (kidney dysfunction)
  2. Hallucination (an experience involving the perception of something not present)
  3. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  4. Hypertension (high blood pressure)
  5. Pain
  6. Partner stress
  7. Social problem
  8. Arthralgia (joint pain)
  9. Chronic kidney disease
  10. Death

What are the common drug interactions of Hydroxyzine Hydrochloride and Anoro Ellipta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anaemia (lack of blood)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Emotional distress
  4. Gait disturbance
  5. Hyperkalaemia (damage to or disease of the kidney)
  6. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  7. Hypertension (high blood pressure)
  8. Pain
  9. Partner stress
  10. Renal failure (kidney dysfunction)

40-49:

  1. Cough
  2. Dyspnoea (difficult or laboured respiration)
  3. Fatigue (feeling of tiredness)
  4. Hyperhidrosis (abnormally increased sweating)
  5. Infection
  6. Influenza
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Muscle spasms (muscle contraction)
  9. Oxygen saturation decreased
  10. Pain in extremity

50-59:

  1. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  2. Pain

60+:

  1. Pain
  2. Dyspnoea (difficult or laboured respiration)
  3. Oropharyngeal pain
  4. Pyrexia (fever)
  5. Respiratory tract infection
  6. Sinusitis (inflammation of sinus)
  7. Viral infection
  8. Bacterial infection
  9. Chest discomfort
  10. Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 7 people, 29.17%
  2. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 20.83%
  3. Parkinson's Disease: 3 people, 12.50%
  4. Pain: 3 people, 12.50%
  5. High Blood Cholesterol: 3 people, 12.50%
  6. Chest Pain: 3 people, 12.50%
  7. Neuralgia (pain in one or more nerves): 2 people, 8.33%
  8. Hypersensitivity: 2 people, 8.33%
  9. High Blood Pressure: 2 people, 8.33%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Hydroxyzine hydrochloride and Anoro ellipta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Hydroxyzine hydrochloride and Anoro ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hydroxyzine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Anoro ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydroxyzine hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Anoro ellipta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on hydroxyzine hydrochloride and umeclidinium bromide; vilanterol trifenatate (the active ingredients of Hydroxyzine hydrochloride and Anoro ellipta, respectively), and Hydroxyzine hydrochloride and Anoro ellipta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: